Identification of angiogenic properties of insulin like growth factor II in in vitro angiogenesis models

British Journal of Cancer

Volumn 82, Issue 2, 2000, Pages 385-391

  Lee, O H ^a   Bae, S K ^a   Bae, M H ^a   Lee, Y M ^a   Moon, E J ^a   Cha, H J ^a   Kwon, Y G ^b   Kim, K W ^a  

^a Pusan National University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

HUVECs; Insulin like growth factor II; Invasion; Migration; Tube formation

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN B;

ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MODEL; NORTHERN BLOTTING; PRIORITY JOURNAL; ZYMOGRAPHY;

EID: 0033965843     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0931     Document Type: Article

References (26)

1. Abedi H and Zachary I (1997) Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272: 15442-15451
2. Albini A, Barillari G, Benell R, Gallo RC and Ensoli B (1995) Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 92: 4838-1842
3. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumour cells. Cancer Res 47: 3239-3245
4. Bar RS, Siddle K, Dolash S, Boes M and Dake B (1988) Actions of insulin and insulin-like growth factors I and II in cultured microvessel endothelial cells from bovine adipose tissue. Metabolism 37: 714-720
5. Bowsher RR, Lee WH, Apathy JM, O'Brien PJ, Ferguson AL and Henry DP (1991) Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology 128: 805-814
6. Cohick WS and Clemmons DR (1993) The insulin-like growth factors. Annu Rev Physiol 55: 131-153
7. Cullen KJ, Smith HS, Hill S, Rosen N and Lippman ME (1991) Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51: 4978-4985
8. Daughaday WH (1990) Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumours. Endocrinology 127: 1-4
9. Dechiara TM, Efstratiadis A and Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80
10. Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43: 175-203
11. Groskopf JC, Syu L-J, Saltiel AR and Linger DIH (1997) Proliferin induces endothelial cell chemotaxis through a G protein-coupled, mitogen-activated protein kinase-dependent pathway. Endocrinology 138: 2835-2840
12. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
13. Hanemaaijer R, Koolwijk P, Le Clercq L, De Vree WJ and Van Hinsbergh VWM (1993) Regulation of matrix metalioproteinase expression in human vein and microvascular endothelial cells. Biochem J 296: 803-809
14. Herron GS, Banda MJ, Clark EJ, Gavrilovic J and Werb Z (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261: 2814-2818
15. Kim K-W, Bae S-K, Lee O-H, Bae M-H, Lee M-J and Park BC (1998) Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58: 348-351
16. Kraft A, Reid LM and Zvibel I (1993) Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells. Cancer Res 53: 652-657
17. Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14: 455-463
18. Minniti CP, Tsokos M, Newton WA Jr and Helman LJ (1994) Specific expression of insulin like growth factor-II in rhabdomyosarcoma tumor cells. Am J Clin Pathol 101: 198-203
19. Nishimoto I (1993) The IGF-II receptor system: a G protein-linked mechanism. Mol Reprod Rev 35: 398-406
20. Reeve AE, Eccles MR, Wilkins RJ, Bell GI and Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317: 258-260
21. Rousseau S, Houle F, Landry J and Huot J (1997) p38 MAP kinase activation by vascular endothelial growth factor mediate actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177
22. Sage EH (1997) Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends in Cell Biology 7: 182-186
23. Stewart CEH and Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Pyshiol Rev 76: 1005-1026
24. Storchenfeldt L, Schofield PN and Engstrom W (1991) Stimulatory effect of insulin-like growth factor II on DNA synthesis in the human embryonic cornea. Cell Biol Int Rep 15: 1217-1223
25. Sullivan KA, Castle VP, Hanash SM and Feldman EL (1995) Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 147: 1790-1798
26. Volpert O, Jackson D, Bouck N and Linzer DI (1996) The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 137: 3871-3876